3Solcia E;K1Oppel G;Sobin LH.Histological Typing of Endocrine Tumors,2000.
4Mark Bloomston,Osama Al-Saif,Dori Klemanski,Joseph J. Pinzone,Edward W. Martin,Bryan Palmer,Gregory Guy,Hooman Khabiri,E. Christopher Ellison,Manisha H. Shah.Hepatic Artery Chemoembolization in 122 Patients with Metastatic Carcinoid Tumor: Lessons Learned[J]. Journal of Gastrointestinal Surgery . 2007 (3)
5M. van der Hoef,D. W. Crook,B. Marincek,D. Weishaupt.Primary neuroendocrine tumors of the liver: MRI features in two cases[J]. Abdominal Imaging . 2004 (1)
6Clayton D. Knox BA,Christopher D. Anderson MD,Laura W. Lamps MD,R. Benton Adkins MD,C. Wright Pinson MD, MBA.Long-Term Survival after Resection for Primary Hepatic Carcinoid Tumor[J]. Annals of Surgical Oncology . 2003 (10)
7K. ?berg.Neuroendocrine gastrointestinal tumors – a condensed overview of diagnosis and treatment[J]. Annals of Oncology . 1999 (2)
8Mizuno Y,Ohkohchi N,Fujimori K,Doi H,Orii T,Asakura T et al.Primary hepatic carcinoid tumor: a case report. Hepato Gastroenterology . 2000
9Donadon M,Torzilli G,Palmisano A,Del Fabbro D,Panizzo V,Maggioni M,et al.Liver resection for primary hepaticneuroendocrine tumours: report of three cases and review of the literature. European Journal of Surgical Oncology . 2006
10van der Horst-Schrivers AN,Post WJ,Kema IP,Links TP,Willemse PH,Wymenga AN,et al.Persistent low urinary excretion of 5-HIAA is a marker for favourable survival during follow-up in patients with disseminated midgut carcinoid tumours. European Journal of Cancer . 2007
4Wang LM, An SL, Wu JX. Diagnosis and therapy of primary he- patic neuroendocrine carcinoma: clinical analysis of 10 cases[ J]. Asian Pacific J Cancer Prevent, 2014,15 ( 6 ) :2541-2546.
5A.rtnbruster M, Sourbron S, Haug A, et al. Evaluation of neuroen- docrine liver metastases a comparison of dynamic contrast-en- hanced magnetic resonance imaging and positron emission tomo- graphy/computed tomography[ J]. Investigative Radiology, 2014, 49(1) :7-14.
6Park CH, Chung JW, Jang SJ, et al. Clinical features and out- comes of primary hepatic neuroendocrine carcinomas [ J ]. J Gastroenterol Hepatol, 2012,27 ( 8 ) : 1306-1311.
7Kudo A, Ban D, Akashi T, et al. Prognoses of GEP-Nets with un- determined malignant potentials of their primary sites[J]. Hepato Gastroenterology, 2012,59( 118 ) : 1682-1686.
8Endo S, Dousei T, Yoshikawa Y, et al. Gastric neuroendocrine tumors in our institutions according to the WHO 2010 classification [ J ]. International Surgery, 2012,97 (4) :335-339.
9Sommer WH, Ceelen F, Garcia-Albeniz X, et al. Defining pre- dictors for long progression-free survival after radioembolisation of hepatic metastases of neuroendocrine origin [ J ]. European Radiology, 2013,23 ( 11 ) : 3094-3103.
10Kim YC, Park MS, Chung YE, et al. MRI findings of uncommon non-hepatocyte origin primary liver turnouts with pathological correlation [ J ]. Br J Radiol, 2010,83 (996) : 1080-1086.
